Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/IDR.S319029 http://scihub22266oqcxt.onion/10.2147/IDR.S319029 34326650!8315284!34326650     free     free     free       Infect+Drug+Resist 2021 ; 14 (?): 2823-2827 Nephropedia Template TP {{tp|p=34326650|t=2021. Delayed SARS-CoV-2 Clearance in Patients with Obesity |pdf=|usr=}}{{34326650}} gab.com Text Delayed SARS-CoV-2 Clearance in Patients with Obesity JO: Infect Drug Resist http://www.kidney.de/pget.php?&tw=1&pmid=34326650 #FOAvip OBJECTIVE: The present study aimed to investigate the correlation between obesity and virus persistence in patients with COVID-19. DESIGN AND METHODS: A total of 57 patients with laboratory-confirmed COVID-19 were admitted to two clinical centers, and data were analyzed retrospectively. Among them, 18 patients with body mass index (BMI) >/= 25 kg/m(2) were diagnosed with obesity, and dynamics of viral replication were compared. RESULTS: Eighteen patients were diagnosed with obesity. The correlations between BMI and white blood cell, C-reactive protein, and cycle threshold (Ct) values of ORF1ab were not significant (all P > 0.05). On day 7 after admission, virus clearance was achieved in 13 (33.3%) patients with BMI < 25 kg/m(2) and 5 (27.8%) patients with BMI >/= 25 kg/m(2) (chi(2) = 0.176, P =0.68). On day 14, the RNA tests were negative in 37 (94.9%) patients with BMI < 25 kg/m(2) and 13 (72.2%) patients with BMI >/= 25 kg/m(2) (chi(2) = 5.865, P = 0.03). Multivariable analysis showed that only BMI >/= 25 kg/m(2) (P = 0.02) was the independent risk factor for virus clearance on day 14. CONCLUSION: Obesity may affect the clearance of SARS-CoV-2, and BMI should be assessed in patients with COVID-19, although they are not seriously ill. Twit Text FOAVip Delayed SARS-CoV-2 Clearance in Patients with Obesity ????Infect Drug Resist http://www.kidney.de/pget.php?&tw=1&pmid=34326650 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34326650 #FOAvip English Wikipedia <ref>{{Cite pmid|34326650}}</ref> Delayed SARS-CoV-2 Clearance in Patients with Obesity #MMPMID34326650 Zhang X; Lin B; Yang G; Liu L; Lu J; Lu Z; Xue Y Infect Drug Resist 2021[]; 14 (?): 2823-2827 PMID34326650show ga OBJECTIVE: The present study aimed to investigate the correlation between obesity and virus persistence in patients with COVID-19. DESIGN AND METHODS: A total of 57 patients with laboratory-confirmed COVID-19 were admitted to two clinical centers, and data were analyzed retrospectively. Among them, 18 patients with body mass index (BMI) >/= 25 kg/m(2) were diagnosed with obesity, and dynamics of viral replication were compared. RESULTS: Eighteen patients were diagnosed with obesity. The correlations between BMI and white blood cell, C-reactive protein, and cycle threshold (Ct) values of ORF1ab were not significant (all P > 0.05). On day 7 after admission, virus clearance was achieved in 13 (33.3%) patients with BMI < 25 kg/m(2) and 5 (27.8%) patients with BMI >/= 25 kg/m(2) (chi(2) = 0.176, P =0.68). On day 14, the RNA tests were negative in 37 (94.9%) patients with BMI < 25 kg/m(2) and 13 (72.2%) patients with BMI >/= 25 kg/m(2) (chi(2) = 5.865, P = 0.03). Multivariable analysis showed that only BMI >/= 25 kg/m(2) (P = 0.02) was the independent risk factor for virus clearance on day 14. CONCLUSION: Obesity may affect the clearance of SARS-CoV-2, and BMI should be assessed in patients with COVID-19, although they are not seriously ill. ?Delayed SARS-CoV-2 Clearance in Patients with Obesity (epmc).pdf DeepDyve Pubget Overpricing